| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.65 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |